Can you have your telomeres measured, and is there any value in doing so?
Having your telomeres measured is possible, but the result of a commercial blood test is difficult to interpret. Measurement protocols are not standardised, blood values say only moderately something about other organs, and a large part of your telomere length is genetically fixed regardless.
Telomeres are the protective caps at the ends of your chromosomes. They get shorter as cells divide and you age. This is why they are considered a possible marker of biological ageing. Measuring them is possible, then, but what you can do with the result is limited.
The most widely used measurement method in commercial tests gives only an average length in your blood. That is a problem: cellular ageing is determined by your shortest telomeres, not the average. Newer research methods do measure the shortest telomeres, sometimes even per individual chromosome end. These are not yet available as a consumer product.
An additional complication: the result depends strongly on how your sample was taken and stored. Sample type (blood, saliva, buccal swab), storage conditions and laboratory protocol all affect the outcome. International standardisation is still lacking. Two measurements from the same person taken in different labs can diverge considerably.
A meta-analysis of 55 studies (4,324 persons, 102 tissues) shows that the correlation between blood telomeres and telomeres in other organs is moderate. What your blood indicates is therefore not necessarily representative of your brain, heart or intestines. Moreover, part of your telomere length is simply determined by heredity: research shows that which chromosome end is relatively long or short is already fixed at birth and remains stable. Your telomere length therefore also says something about your genes, not only about your lifestyle.
It is not entirely without value. In research into specific conditions, such as severe precursors of cervical cancer, the combination of telomere length, telomerase activity (the enzyme that replenishes telomeres) and HPV typing shows a distinctive pattern. But that is a research tool. For you as a consumer, the result is a rough indication, not a personal action plan, and comparability over time is not guaranteed as long as protocols have not been standardised.
Based on multiple scientific publications (2009-2024), including a meta-analysis of 55 studies. The studies are predominantly associative in design; causal conclusions are not possible. No RCTs are available for diagnostic value. Commercial interests in consumer tests were not assessed in the underlying studies.